Day: December 8, 2017

Annual Changes to the NASDAQ-100 Index

NEW YORK, Dec. 08, 2017 (GLOBE NEWSWIRE) — Nasdaq (Nasdaq:NDAQ) today announced the results of the annual re-ranking of the NASDAQ-100 Index® (Nasdaq:NDX), which will become effective prior to market open on Monday, December 18, 2017. The following five companies will be added to the Index: ASML Holding N.V. (Nasdaq:ASML), Cadence Design Systems, Inc. (Nasdaq:CDNS), Synopsys, Inc. (Nasdaq:SNPS), Take-Two Interactive Software, Inc. (Nasdaq:TTWO) and Workday, Inc. (Nasdaq:WDAY). The NASDAQ-100 Index is composed of the 100 largest non-financial companies listed on The NASDAQ Stock Market® and dates to January 1985 when it was launched along with the NASDAQ Financial-100 Index®, which

Annual Changes to the NASDAQ Biotechnology Index

NEW YORK, Dec. 08, 2017 (GLOBE NEWSWIRE) — Nasdaq (Nasdaq:NDAQ) today announced the results of the annual re-ranking of the NASDAQ Biotechnology Index (Nasdaq:NBI), which will become effective prior to market open on Monday, December 18, 2017. The following 54 securities will be added to the Index: Exchange SYMBOL COMPANY NAME Nasdaq ABUS Arbutus Biopharma Cp Nasdaq ACRS Aclaris Therapeutics, Inc. Nasdaq ADAP Adaptimmune Theraptcs plc Nasdaq AKAO Achaogen, Inc. Nasdaq AKCA Akcea Therapeutics, Inc. Nasdaq ANAB AnaptysBio, Inc. Nasdaq ASND Ascendis Pharma Nasdaq ATNX Athenex, Inc. Nasdaq AUPH Aurinia Pharmaceuticals Nasdaq AXON Axovant Sciences Ltd Nasdaq BIVV Bioverativ Inc.

Top 10 Semi-Finalists Announced for 15th Annual Small Business BC Awards

VANCOUVER, British Columbia, Dec. 08, 2017 (GLOBE NEWSWIRE) — Small Business BC, the province’s premier resource for entrepreneurs, and Canada Post asked the public to nominate their favourite small businesses in British Columbia for this year’s 15th Annual Small Business BC Awards. Nearly 600 businesses were nominated and tasked with gaining as many votes as they could. The ten who received the most votes have made it into the semi-finals of the awards. As the largest small business awards competition in British Columbia, these awards not only recognize the outstanding achievements of local entrepreneurs, they also provide a powerful platform

Associa Cares Donates up to $100,000 for California Fire Relief

Dallas, TX, Dec. 08, 2017 (GLOBE NEWSWIRE) — Associa, the industry’s largest community management company, has earmarked up to $100,000 to assist homeowners affected by the Southern California fires and organizations assisting the victims through their national nonprofit, Associa Cares. As the devastating, rapidly spreading fires continue to sweep across the southern part of the state, thousands of Californians have been forced to evacuate their homes. The fires are destroying buildings, homes and land. “As the fires continue to rage across the area, we wanted to assist residents and let them know that Associa stands with them during this unpredictable

Assembly Biosciences Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

INDIANAPOLIS, Dec. 08, 2017 (GLOBE NEWSWIRE) — Assembly Biosciences, Inc. (NASDAQ:ASMB), a clinical-stage biotechnology company advancing a new class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel oral live biotherapeutics for disorders associated with the microbiome, today announced grants of options to four new employees to purchase an aggregate of 10,400 shares of Assembly’s common stock with an exercise price of $44.28 per share, the closing price on December 8, 2017. The stock options have a ten-year term and vest over four years, with one-fourth vesting on the first anniversary of the date of

Myriad Genetics Presents Results From Two Important EndoPredict® Studies at the 2017 San Antonio Breast Cancer Symposium

SALT LAKE CITY, Dec. 08, 2017 (GLOBE NEWSWIRE) — Myriad Genetics, Inc. (NASDAQ:MYGN), a leader in molecular diagnostics and personalized medicine, today announced new results from two studies with EndoPredict® are being featured at the 2017 San Antonio Breast Cancer Symposium (SABCS) in San Antonio, Texas.  EndoPredict is a second-generation prognostic gene expression test for patients with breast cancer.“We are excited to present new data on our EndoPredict test which demonstrates our ongoing commitment to collaborate with leading academic research centers and advance personalized medicine for patients with breast cancer,” said Ralf Kronenwett, M.D., Ph.D., director of International Medical Affairs,

Pele Mountain Announces $1.3 Million in Debt Settlements and Waivers of Fees and Salaries

NOT FOR DISSEMINATION IN THE UNITED STATES OR OVER UNITED STATES NEWSWIRE SERVICES TSXV:   GEMShares Outstanding:  20,999,693 TORONTO, Dec. 08, 2017 (GLOBE NEWSWIRE) — Pele Mountain Resources Inc. (TSXV:GEM) (“Pele” or the “Corporation”) announces that further to its press release dated November 24, 2017, it has entered into agreements with certain creditors (“Creditors”), including Creditors who are related parties of the Corporation, providing for the settlement of approximately $1,213,457 of its outstanding debts (the “Debt Settlement”). Pursuant to the Debt Settlement, approximately $964,047 in debt will be settled through the issuance of an aggregate of 12,630,902 common shares of the

TMS Market Update

VANCOUVER, British Columbia, Dec. 08, 2017 (GLOBE NEWSWIRE) — Targeted Microwave Solutions Inc. (TSX-V:TMS) (FRA:A2ACNT) (OTCQB:TGTMF) (“TMS” or the “Company”) is issuing this press release in response to a request by the Investment Industry Regulatory Organization of Canada to comment on recent trading activity of its stock. TMS announces that it is not aware of any material, undisclosed corporate developments and has no material change to report at this time. The Company will keep the market informed as required. On behalf of the Board of Directors,“Dr. James Young”Chief Executive Officer and Chairman About Targeted Microwave Solutions Inc. Targeted Microwave Solutions

PIMCO Closed-End Funds Declare Special Year-End Distribution

NEW YORK, Dec. 08, 2017 (GLOBE NEWSWIRE) — The Board of Trustees/Directors of the PIMCO closed-end funds has declared a special year-end distribution for PCM Fund, Inc. (the “Fund”) common shares as summarized below. This distribution is payable on December 22, 2017 to shareholders of record on December 18, 2017, with an ex-dividend date of December 15, 2017. In addition to the regular monthly dividend, this special year-end distribution is being paid to allow the Fund to meet its 2017 distribution requirements for federal excise tax purposes. The Fund’s total distribution will be taxable to shareholders in 2017. Fund NYSE

The Klein Law Firm Notifies Investors of a Class Action Filed on Behalf of CenturyLink, Inc. Senior Note Holders and a Lead Plaintiff Deadline of December 26, 2017 (CTL)

NEW YORK, Dec. 08, 2017 (GLOBE NEWSWIRE) — The Klein Law Firm announces that a class action complaint has been filed on behalf investors who purchased 7.60% Senior Notes, Series P, due 2039, of CenturyLink, Inc. (NYSE:CTL) between March 1, 2013 and June 19, 2017. The action, which was filed in the United States District Court for the Southern District of New York, alleges that the Company violated federal securities laws. The complaint alleges that defendants during the Class Period made false and misleading statements and/or failed to disclose that: (1) CenturyLink’s policies allowed its employees to add services or

JDRF welcomes CRA review of diabetes denials

TORONTO, Dec. 08, 2017 (GLOBE NEWSWIRE) — The 300,000+ Canadians and their families living with type 1 diabetes (T1D) across the country welcome today’s announcement that the Government of Canada and the Canada Revenue Agency (CRA) will rescind new letters introduced in May that made it virtually impossible for adults with T1D to qualify for the disability tax credit (DTC). CRA has also committed to review all applications denied under the post-May 2017 process. In collaboration with JDRF and Diabetes Canada, members of the T1D community rallied together this past month to express their outrage and disappointment over a decision

Improper use of holiday laser lights could pose threat to aviation safety

OTTAWA, Dec. 08, 2017 (GLOBE NEWSWIRE) — NAV CANADA is reminding people to be cautious when installing decorative laser lights this holiday season. Laser projectors that shine festive displays on houses must be aimed at solid surfaces and not towards the sky. Skyward beams can enter the cockpit of an aircraft and pose a risk to pilots. NAV CANADA says many people are surprised to learn that these popular holiday light kits can be as potentially dangerous as other type of lasers. Consumers are asked to read the warning labels on the package and carefully follow the directions when setting

ARC Group Worldwide Announces Its Intent to Pursue a Rights Offering

DELAND, Fla., Dec. 08, 2017 (GLOBE NEWSWIRE) — ARC Group Worldwide, Inc. (“ARC” or the “Company”) (NASDAQ:ARCW), a leading global provider of advanced manufacturing and metal 3D printing solutions, today announced its intent to commence a rights offering pursuant to which it plans to raise approximately $10.0 million through the distribution of subscription rights and the exercise thereof.  The rights will entitle the security holders to purchase shares of the Company’s common stock.  The Company has filed with the Securities and Exchange Commission (the “Commission”) a registration statement under the Securities Act of 1933, as amended, in order to effect the rights

Canoe EIT Income Fund Announces 2017 Annual Redemption Price

Not for Distribution to U.S. Newswire Services or for Dissemination in the United States of America. CALGARY, Alberta, Dec. 08, 2017 (GLOBE NEWSWIRE) — Canoe EIT Income Fund (“Canoe” or the “Fund”) (TSX:EIT.UN) today announced that units accepted for the 2017 voluntary cash redemption will be redeemed at a price of $11.81 per unit in Canadian dollars.  This price is equal to 95% of the average net asset value per unit based on the three business days preceding the redemption date of December 8, 2017, less direct costs.  Payment of the redemption proceeds will be made on or before January 3,

Excelsior Files Final Base Shelf Prospectus

Not for dissemination or distribution in the United States or through U.S. newswire services. VANCOUVER, British Columbia, Dec. 08, 2017 (GLOBE NEWSWIRE) — Excelsior Mining Corp. (TSX:MIN) (FSE:3XS) (OTCQX:EXMGF) (“Excelsior” or the “Company”) is pleased to announce that it has filed a final base shelf prospectus (the “Shelf Prospectus“) with the securities regulatory authorities in each of the provinces of Canada (other than Quebec). The Shelf Prospectus will enable Excelsior to make offerings of up to US$30,000,000 of any combination of common shares, debt securities, subscription receipts, units, warrants and share purchase contracts, during the 25-month period that the Shelf Prospectus,

Parks! America Reports Record Results for the Fourth Consecutive Year

Fiscal Year Reported Net Income – $1.26 million Fiscal Year Adjusted Net Income – $1.21 million, an increase of $417,333 Comparable 52-week attendance revenues increase $1.23 million or 25.0% Double-digit percentage growth in attendance based net sales in 12 of the last 14 fiscal quarters PINE MOUNTAIN, Ga., Dec. 08, 2017 (GLOBE NEWSWIRE) —  Parks! America, Inc. (OTCPink:PRKA), today announced the results for its fourth quarter and fiscal year ended October 1, 2017. “We are pleased to announce that our 2017 fiscal year total net sales of $6,238,264 and adjusted net income of $1,211,154 each reflect the fourth consecutive year

Oil-Dri Announces First Quarter Fiscal 2018 Results

CHICAGO, Dec. 08, 2017 (GLOBE NEWSWIRE) — Oil-Dri Corporation of America (NYSE:ODC), producer and marketer of sorbent mineral products supplying pet care, animal health, fluids purification, agricultural ingredient, sports field, industrial and automotive markets, today announced its first quarter fiscal 2018 earnings. Oil-Dri reported the following key metrics (As of October 31, 2017, compared to the same period of the prior year): Net sales of $66,646,000, flat Net income of $3,050,000, up 52% Earnings per diluted share of $0.41, up 46%  Business-to-Business Products Group Net sales of $27,087,000, down 1% Segment operating income of $ 8,876,000, down 6%  Retail and

Focus Graphite Announces Update on Private Placement

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES OTTAWA, Dec. 08, 2017 (GLOBE NEWSWIRE) — Focus Graphite Inc. (TSX-V:FMS) (OTCQX:FCSMF) (FSE:FKC) (“Focus” or the “Company”) is pleased to provide an update following the first closing of its current flow-through offering (the “Offering”) for gross proceeds of $1,290,000 (see the Company’s press release dated November 7, 2017 for more details on the Offering). The Company expects to proceed with the closing of the second tranche shortly and has elected to increase the Offering for an additional 25 million flow-through shares at a price of $0.08

Adamas Announces New Employment Inducement Grant

EMERYVILLE, Calif., Dec. 08, 2017 (GLOBE NEWSWIRE) — Adamas Pharmaceuticals, Inc. (Nasdaq:ADMS) today announced that the compensation committee of the company’s board of directors granted 64 new employees the option to purchase an aggregate of 77,550 shares of the company’s common stock, at a per share exercise price of $35.76, the closing trading price on December 7, 2017, and restricted stock units to acquire 38,775 shares of the company’s common stock. The stock option and restricted stock units vest over four years and were granted pursuant to the Adamas Pharmaceuticals, Inc. 2016 Inducement Plan, which was approved by the company’s

Akari Therapeutics Announces Phase II COBALT trial of Coversin™ in Patients with PNH Met the Primary Endpoint

Last three patients enrolled into the Phase II COBALT trial on the new dosing regimen (45 mg per Day) saw a more rapid decline in LDH than those in the original dosing regimen. The Day 28 Endpoint was less than or equal to 1.5 x ULN for all three patients.  The new dosing regimen at 45 mg per day is expected to be used in the Phase III trials Company to host and webcast investor and analyst event December 10, 2017, at 8:00 p.m. ET NEW YORK and LONDON, Dec. 08, 2017 (GLOBE NEWSWIRE) — Akari Therapeutics, Plc (NASDAQ:AKTX), a